Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
4
×
national top stories
startups
biotech
boston
boston top stories
clinical trials
deals
cancer
crispr
new york blog main
san francisco blog main
san francisco top stories
sanofi
abbvie
adeno-associated virus
akouos
allergan
allosteric
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
atlas venture
atopic dermatitis
autoimmune disorders
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
brace pharma
cancer immunotherapy
cerovene
chemotherapy
cisplatin
cleva pharma
covid-19
What
medicines
4
×
years
4
×
ago
bio
therapeutics
acquisitions
adding
address
adds
aiming
allosteric
announced
balance
build
ceo
clinic
collabs
covid
create
crispr
daniel
deal
decibel
diagnostic
disease
diseases
drugs
editing
elusive
emerged
fix
focus
forms
gene
gilead
gilead’s
hearing
heats
help
high
Language
unset
Current search:
" national blog main "
×
medicines
×
years
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M